Eurazeo SE (RF) Fair Value & Analysis
Financial Services · FR · Market cap €3.0B
Fair value as of: Jun 26, 2026
From 9 valuation models · updated 3 days ago
Share price −14.2% over the past month.
Price vs Fair Value (12 months)
12‑month range €35.81 – €61.27 · fair‑value band €24.88 – €70.56 · the €40.30 price screens below the €48.07 fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Eurazeo SE (RF) currently trades at €40.30, while our model-based Fair Value estimate is €48.07 — implying the stock looks roughly 19.3% undervalued today. We read business quality at 91/100 (high quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Trailing-twelve-month revenue stands at €42.7M. Revenue declined 39.2% year over year. It earns a return on equity of -5.9%. Net debt stands at €1.1B. Fundamentals as of Jun 26, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
Eurazeo SE is a private equity and venture capital firm specializing in growth capital, series C, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in upper mid-market, mid-market and listed public companies, small- and mid-cap healthcare companies, equity in the small-mid and mid-large buyout segments. The firm seeks to invest in medium-sized or large companies, SMEs, high growth companies, and real estate management and investment activities. It does not have any restrictions regarding the sectors in which it invests but prefers to invest in smart cities, services, leisure and mobility, real estate, fintech, investment activities, distribution, industry, luxury, consumer goods, business services, consumer and retail brands, and health sectors. The firm seeks to invest in consumer brands with a focus on beauty, digital health, life science, tech, financial services, personal care, household care, juvenile products, apparel, wellness, accessories, ho…
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Eurazeo SE reported revenue of €468M in FY2025 versus €6.1B in FY2021, a compound −47.5%/yr. Reported net income was −€404M in FY2025.
Open the full interactive analysis →
Similar stocks
6 more Asset Management stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Fondul Proprietatea SA FP | $0.0420 | $0.0800 | +90% |
| The Schiehallion Fund Limited MNTN | $2.27 | $4.54 | +100% |
| BlackRock, Inc BLK | 17,417 MXN | 11,340 MXN | -35% |
| BH Macro Limited BHMU | $4.42 | $8.84 | +100% |
| Blackstone Inc BX | $118.48 | $55.81 | -53% |
| Investor AB IVSBF | $40.08 | $80.15 | +100% |
Explore undervalued stocks
More undervalued Financial Services stocks →
Frequently asked questions
Is Eurazeo SE (RF) undervalued?
What is the fair value of RF?
What is the quality score of RF?
What is the revenue of Eurazeo SE (RF)?
What is the net profit margin of RF?
Does Eurazeo SE pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.